摘要
卵巢癌是常见妇科肿瘤,已成为严重威胁妇女生命和健康的主要肿瘤。由于卵巢癌早期病变不易发现,且缺乏有效的筛查方法,大部分患者获得确诊时已为中晚期,因此早期诊断对卵巢癌患者故为重要。应用多种血清肿瘤标志物的联合检测能提高卵巢癌诊断准确性,并降低卵巢癌诊断的漏诊率,同时也有助于临床治疗中的疗效评价及预后判断。
Ovarian cancer is a common gynecological tumor, has become a serious threat to women＇s life and health of the main tumor. Because there is no symptom in the early stage and lack of effective screening method, most of people who are diagnosed ovarian cancer is Mid-term and late period. Therefore, diagnosis of ovarian cancer patients is an important reason. With the application of combined measurement of tumor markers, it can assist ovarian cancer diag- nosis accuracy in the early stage and reduce the missed diagnosis of ovarian cancer, and at the same time, it can also helps in the clinical treatment effect and prognosis judgement.
出处
《中国当代医药》
2013年第10期23-24,31,共3页
China Modern Medicine
